PBAC Public Summary Documents – May 2024
Page last updated: 30 August 2024
Public Summary Documents relating to the May 2024 PBAC meeting.
- Aflibercept (CNV): Solution for intravitreal injection 11.34 mg in 100 microlitres (114.3 mg per mL); Eylea®
- Aflibercept (DMO): Solution for intravitreal injection 11.34 mg in 100 microlitres (114.3 mg per mL); Eylea®
The following Public Summary Document has been updated:
March 2024 PBAC meeting